Log in
Enquire now

List of Vyne Therapeutics patents

List of Vyne Therapeutics patents
List of Isuzu Motors patents
List of Design Ideas Limited patents
List of Origami Owl patents
Weather forecasting venture capital investors
List of SBIR/STTR awards granted to Lasson Technologies
Patents where
Current Assignee
Name
is
Vyne TherapeuticsVyne Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11033491 Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof

Patent 11033491 was granted and assigned to Vyne Therapeutics on June, 2021 by the United States Patent and Trademark Office.

Vyne Therapeutics
Vyne Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11033491
June 15, 2021
‌
US Patent 10967063 Surfactant-free, water-free formable composition and breakable foams and their uses

Patent 10967063 was granted and assigned to Vyne Therapeutics on April, 2021 by the United States Patent and Trademark Office.

Vyne Therapeutics
Vyne Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10967063
April 6, 2021
‌
US Patent 10946101 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses

Patent 10946101 was granted and assigned to Vyne Therapeutics on March, 2021 by the United States Patent and Trademark Office.

Vyne Therapeutics
Vyne Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10946101
March 16, 2021
‌
US Patent 11103454 Wax foamable vehicle and pharmaceutical compositions thereof

Patent 11103454 was granted and assigned to Vyne Therapeutics on August, 2021 by the United States Patent and Trademark Office.

Vyne Therapeutics
Vyne Therapeutics
Vyne Therapeutics
Vyne Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11103454
August 31, 2021
‌
US Patent 11026920 Use of NK-1 receptor antagonist serlopitant in pruritus

Patent 11026920 was granted and assigned to Vyne Therapeutics on June, 2021 by the United States Patent and Trademark Office.

Vyne Therapeutics
Vyne Therapeutics
Vyne Therapeutics
Vyne Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11026920
June 8, 2021
5 results
0 selected
5 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us